"A Window Trial on Boswellia for Breast Cancer Primary Tumors"

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2017

Primary Completion Date

April 29, 2024

Study Completion Date

April 29, 2024

Conditions

Breast Cancer

Interventions

DRUG

Boswellia

Boswellia is an extract from frankincense

Trial Locations (1)

Medical University of South Carolina, Charleston

All Listed Sponsors

lead

Medical University of South Carolina

OTHER

NCT03149081 - "A Window Trial on Boswellia for Breast Cancer Primary Tumors" | Biotech Hunter | Biotech Hunter